Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
 
Secure Logon Learn More 
* For Financial Representatives *
and Operations Personnel Only
User Id:
Password:
 
Help, I Forgot My Password!
Benefits of Registration

Commentary
Subscribe to First Trust commentary and analysis.

Bob Carey
Chief Market Strategist
Blog
Brian Wesbury
Chief Economist
Blog
Investment Insights
FINRA's BrokerCheck
Check the background of
First Trust using FINRA's BrokerCheck.
Factoid of the Day Friday, September 13, 2019
The U.S. Food and Drug Administration (FDA) has approved 27 new drugs this year (thru 9/12), down from 35 approvals at this point last year, according to its own release. The FDA approved an all-time high of 59 new drugs in 2018. Tufts Center for the Study of Drug Development estimates that drug companies, on average, endure out-of-pocket costs approaching $1.4 billion for newly developed, FDA-approved prescription medicines, according to Policy & Medicine.
 
Brian Wesbury - Economic Video Commentary
Negative Interest Rates are Fool's Gold

Bob Carey - Video Market Update
A Correction ... and Nothing More

ETF – Listing Date: August 20, 2019
First Trust EIP Carbon Impact ETF (ECLN)


  Unit Investment Trusts Upcoming Deposit Information Initial Offer Date
  Click Here  for CUSIP Information.

Automated Quantitative Analysis, 19 9/16/2019
Core Three Closed-End Allocation, 41 9/16/2019
Municipal Income Select, Closed-End, 105 9/16/2019
Dividend Growers and Tax-Advantaged Income, 20 9/17/2019
Dow Jones Global Titans, 29 9/18/2019
International High Dividend Equity, 38 9/18/2019
Strategic Income Select Closed-End, 41 9/18/2019
Precious Metals Select, 42 9/19/2019
Sabrient Baker's Dozen, September 2019 9/20/2019
Brookmont Equity Dividend, 21 9/23/2019
Deep Value Dividend Opportunity, 10 9/23/2019
NextGen Communications and Technology, 3 9/23/2019
Senior Loan & Limited Duration Opportunities Closed-End, 64 9/23/2019
Stonebridge Preferred Income, 24 9/23/2019
Equity Closed-End, 55 9/25/2019
Global Equity Income Closed-End, 67 9/25/2019
Senior Loan & Limited Duration Closed-End, 91 9/25/2019
Emerging Markets Strength, 46 9/27/2019
Income Dividend Equity Allocation (IDEA), 22 9/27/2019
Richard Bernstein Advisors Quality Income, 35 9/27/2019
FT Equity Allocation ETF Model, 4th Qtr 2019 9/30/2019
FT High Income Model, 4th Qtr 2019 9/30/2019
Pacific Northwest, 3 10/2/2019
ETF Growth and Income, October 2019 10/3/2019
Diversified Equity Strategic Allocation, 4th Qtr 2019 10/9/2019
Dow® Target 10, October 2019 10/10/2019
Dow® Target 5, 4th Qtr 2019 10/10/2019
Dow® Target Dividend, 4th Qtr 2019 10/10/2019
European Target High Quality Dividend, 4th Qtr 2019 10/10/2019
Global Target 15, 4th Qtr 2019 10/10/2019
Income Allocation Closed-End, 4th Qtr 2019 10/10/2019
S&P Dividend Aristocrats Target 25, 4th Qtr 2019 10/10/2019
S&P Target 24, 4th Qtr 2019 10/10/2019
S&P Target SMid 60, 4th Qtr 2019 10/10/2019
Target Diversified Dividend, 4th Qtr 2019 10/10/2019
Target Diversified Global Allocation, 4th Qtr 2019 10/10/2019
Target Dividend Blend, 4th Qtr 2019 10/10/2019
Target Dividend Double Play, 4th Qtr 2019 10/10/2019
Target Double Play, 4th Qtr 2019 10/10/2019
Target Focus Four, 4th Qtr 2019 10/10/2019
Target Global Dividend Leaders, 4th Qtr 2019 10/10/2019
Target Growth, 4th Qtr 2019 10/10/2019
Target High Quality Dividend, 4th Qtr 2019 10/10/2019
Target Triad, 4th Qtr 2019 10/10/2019
Target VIP, 4th Qtr 2019 10/10/2019
Value Line® Target 25, 4th Qtr 2019 10/10/2019
Value Line® Target Safety 30, 4th Qtr 2019 10/10/2019
40/60 Strategic Allocation, 4th Qtr 2019 10/11/2019
60/40 Strategic Allocation, 4th Qtr 2019 10/11/2019
75/25 Strategic Allocation, 4th Qtr 2019 10/11/2019
Diversified Fixed Income ETF, 41 10/11/2019
First Trust Mobile
Learn about our Mobile SiteGet the latest First Trust product and research information on your smartphone or tablet device!
Learn more...

Institutional Investors
Unit Investment Trusts
Variable Annuities
Closed-End Funds
Exchange-Traded Funds
Open End Mutual Funds

Structured Products
Seperate Managed Accounts

401k

First Trust Indexes
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial advisors are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2019 All rights reserved.